Found: 713
Select item for more details and to access through your institution.
Case Report: Cefepime Induced Neurotoxicity Following a Change in Infusion Time.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 4, p. 411, doi. 10.1177/00185787241237142
- By:
- Publication type:
- Article
Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, n. 12, p. 509, doi. 10.1093/ajhp/zxae038
- By:
- Publication type:
- Article
Intravenous push antibiotics in the emergency department: Education and implementation.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, n. 12, p. 531, doi. 10.1093/ajhp/zxae039
- By:
- Publication type:
- Article
A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP).
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64444-3
- By:
- Publication type:
- Article
Cefepime/Enmetazobactam: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 737, doi. 10.1007/s40265-024-02035-2
- By:
- Publication type:
- Article
Antimicrobial Resistance and Associated Risk Factors for Clostridium difficile in Patients Attending Tertiary Care Settings.
- Published in:
- Journal of Tropical Medicine (16879686), 2024, v. 2024, p. 1, doi. 10.1155/2024/6613120
- By:
- Publication type:
- Article
Seraph 100 Microbind Affinity Blood Filter Does Not Clear Antibiotics: An Analysis of Antibiotic Concentration Data from PURIFY-OBS.
- Published in:
- Blood Purification, 2024, v. 53, n. 5, p. 284, doi. 10.1159/000531951
- By:
- Publication type:
- Article
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1093, doi. 10.1093/jac/dkae076
- By:
- Publication type:
- Article
Effectiveness of cephalosporins in hydrolysis and inhibition of Staphylococcus aureus and Escherichia coli biofilms.
- Published in:
- Journal of Veterinary Science, 2024, v. 25, n. 3, p. 1, doi. 10.4142/jvs.23258
- By:
- Publication type:
- Article
Fellows Column: Case Report: Neonatal Intraventricular Hemorrhage in E.coli K1 Meningitis.
- Published in:
- Neonatology Today, 2024, v. 19, n. 4, p. 30
- By:
- Publication type:
- Article
Antimicrobial resistance burden pre and post-COVID-19 pandemic with mapping the multidrug resistance in Egypt: a comparative cross-sectional study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56254-4
- By:
- Publication type:
- Article
Antimicrobial resistance patterns and empiric antibiotic selections for patients admitted from post–acute care facilities.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, p. S8, doi. 10.1093/ajhp/zxad290
- By:
- Publication type:
- Article
Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 229, doi. 10.3390/antibiotics13030229
- By:
- Publication type:
- Article
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 285, doi. 10.3390/antibiotics13030285
- By:
- Publication type:
- Article
Association between piperacillin/tazobactam use and acute kidney injury in critically ill patients: a retrospective multicentre cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 552, doi. 10.1093/jac/dkae001
- By:
- Publication type:
- Article
Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey data.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 632, doi. 10.1093/jac/dkae015
- By:
- Publication type:
- Article
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 8, p. 707, doi. 10.1001/jama.2023.27897
- By:
- Publication type:
- Article
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 8, p. 708, doi. 10.1001/jama.2023.27894
- By:
- Publication type:
- Article
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 8, p. 708, doi. 10.1001/jama.2023.27900
- By:
- Publication type:
- Article
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 8, p. 709, doi. 10.1001/jama.2023.27891
- By:
- Publication type:
- Article
Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 2, p. 213, doi. 10.1007/s10096-023-04715-5
- By:
- Publication type:
- Article
Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol: which are the best present and future therapeutic alternatives?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 2, p. 339, doi. 10.1007/s10096-023-04732-4
- By:
- Publication type:
- Article
Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 1, p. 80, doi. 10.1177/08971900221125518
- By:
- Publication type:
- Article
Cefepime-Associated Neurotoxicity in a Pediatric Patient With Stage V Chronic Kidney Disease.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 1, p. 243, doi. 10.1177/08971900221125000
- By:
- Publication type:
- Article
Negative myoclonus as a manifestation of cefepime neurotoxicity.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Pharmacokinetic Analysis of Intravenous Push Cefepime in Burn Patients with Augmented Renal Clearance.
- Published in:
- Journal of Burn Care & Research, 2024, v. 45, n. 1, p. 151, doi. 10.1093/jbcr/irad134
- By:
- Publication type:
- Article
Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia.
- Published in:
- Advances in Pharmacological & Pharmaceutical Sciences, 2023, p. 1, doi. 10.1155/2023/7684613
- By:
- Publication type:
- Article
The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 12, p. 1666, doi. 10.3390/antibiotics12121666
- By:
- Publication type:
- Article
Cefepime Versus Piperacillin-Tazobactam for the Treatment of Intra-Abdominal Infections Secondary to Potential AmpC Beta-Lactamase-Producing Organisms.
- Published in:
- Hospital Pharmacy, 2023, v. 58, n. 6, p. 575, doi. 10.1177/00185787231170384
- By:
- Publication type:
- Article
The Effect of Vancomycin and Piperacillin-Tazobactam on Incidence of Acute Kidney Injury in Patients With Obesity.
- Published in:
- Hospital Pharmacy, 2023, v. 58, n. 6, p. 605, doi. 10.1177/00185787231172388
- By:
- Publication type:
- Article
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2801, doi. 10.1093/jac/dkad244
- By:
- Publication type:
- Article
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2705, doi. 10.3390/pharmaceutics15122705
- By:
- Publication type:
- Article
BIChromET: A Chromogenic Culture Medium for Detection of Piperacillin/Tazobactam and Cefepime Resistance in Pseudomonas aeruginosa.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 11, p. 1573, doi. 10.3390/antibiotics12111573
- By:
- Publication type:
- Article
Critical Commentary on the paper: Compatibility of prolonged infusion antibiotics during Y‐site administration with parenteral nutrition.
- Published in:
- Nursing in Critical Care, 2023, v. 28, n. 6, p. 1204, doi. 10.1111/nicc.12910
- By:
- Publication type:
- Article
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 11, p. 1112, doi. 10.1002/phar.2766
- By:
- Publication type:
- Article
In silico evaluation of a beta‐lactam dosing guideline among adults with serious infections.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 11, p. 1121, doi. 10.1002/phar.2753
- By:
- Publication type:
- Article
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 16, p. 1557, doi. 10.1001/jama.2023.20583
- By:
- Publication type:
- Article
PREVALENCE OF URINARY TRACT INFECTION AND ITS BACTERIOLOGICAL PROFILE AND THE DRUG RESISTANCE PATTERN OF THE PATIENTS AT A TERTIARY CARE CENTRE IN UTTAR PRADESH, INDIA.
- Published in:
- Biochemical & Cellular Archives, 2023, v. 23, n. 2, p. 1217, doi. 10.51470/bca.2023.23.2.1217
- By:
- Publication type:
- Article
In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 10, p. 2423, doi. 10.1007/s11095-023-03608-8
- By:
- Publication type:
- Article
Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 5887, doi. 10.2147/IDR.S426111
- By:
- Publication type:
- Article
In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 6061, doi. 10.2147/IDR.S420898
- By:
- Publication type:
- Article
The Impact of ESBLs-Positive Escherichia coli's Resistance to Cefepime and Its Guidance for Clinical Treatment.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 6395, doi. 10.2147/IDR.S427836
- By:
- Publication type:
- Article
Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2140, doi. 10.1093/jac/dkad192
- By:
- Publication type:
- Article
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2170, doi. 10.1093/jac/dkad211
- By:
- Publication type:
- Article
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2242, doi. 10.1093/jac/dkad229
- By:
- Publication type:
- Article
Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1428, doi. 10.1177/10781552221131901
- By:
- Publication type:
- Article
Comparison of Outcomes in Neonates Receiving Cefepime or Ceftazidime.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2023, v. 28, n. 5, p. 439, doi. 10.5863/1551-6776-28.5.439
- By:
- Publication type:
- Article
In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates.
- Published in:
- Microorganisms, 2023, v. 11, n. 9, p. 2158, doi. 10.3390/microorganisms11092158
- By:
- Publication type:
- Article
Viability and Virulence of Listeria monocytogenes in Poultry.
- Published in:
- Microorganisms, 2023, v. 11, n. 9, p. 2232, doi. 10.3390/microorganisms11092232
- By:
- Publication type:
- Article
Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study.
- Published in:
- Pathogens, 2023, v. 12, n. 9, p. 1152, doi. 10.3390/pathogens12091152
- By:
- Publication type:
- Article